Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0000313143-14-000130

President & CEO sold 4,765 shares at $35.86 ($170,888)

  • President & CEO acquired 4,765 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

CONCANNON BRIAN · President & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2014-11-03 Exercise or conversion : show line 1 in the form +4,765 $27.28 $129,965 151,805 D
2014-11-03 Sale : show line 2 in the form −4,765 $35.86 $170,888 147,040 D
Open-market sales · 4,765 sh · avg $35.86 · $170,888

Table II: Derivative

1 line
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2014-11-03 Exercise or conversion : show line 3 in the form Non-Qualified Stock Option (right to buy) −4,765 $35.86 $170,888 $27.28 2015-10-22 4,765 52,411 D
Loading xslF345X03/edgardoc.xml…